Pharma Must "Continue to Take Chances" In Policy World: Merck VP's Parting Advice
This article was originally published in RPM Report
Executive Summary
A conversation with Merck VP-global public policy Ian Spatz about the challenges and opportunities facing industry amid the changes in Washington.